It should be noted that F3T3 gliomas lacking pTERT mutations, those having other FGFR3::TACC3 fusions besides FGFR3 (ex17)::TACC3 (ex11), or those resected from patients younger than 40 years exhibit a significantly better prognosis [12]. The gene discussed is TACC3; the disease is central nervous system cancer.